← Back
Data updated: Mar 10, 2026
APOZEAL PHARMS
Pharmaceuticals
APOZEAL PHARMS is a generic drug manufacturer with 6 FDA-approved products.
2009
Since
6
Drugs
-
Trials
78
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HYDROXYZINE HYDROCHLORIDE 2025-12-16
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF 2025-11-25
Manufacturing (CMC)
RISPERIDONE 2025-11-04
Labeling
RISPERIDONE 2025-09-11
Labeling
RISPERIDONE 2025-09-02
RISPERIDONE 2025-09-02
CETIRIZINE HYDROCHLORIDE 2025-08-29
Manufacturing (CMC)
RISPERIDONE 2025-08-13
Labeling
RISPERIDONE 2025-08-13
Labeling
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY 2025-08-01
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (5)
Company Info
- First Approval
- 2009-03-30
- Latest
- 2025-07-11
- Applications
- 5